Literature DB >> 3108025

HBV pre-vaccination screening in hospital personnel: cost-effectiveness analysis.

G Corrao, C Zotti, F Tinivella, A Moiraghi Ruggenini.   

Abstract

The purpose of this study was to identify the most cost-effective method for screening subjects for hepatitis B vaccination. Such a method would ideally permit detection of all susceptible individuals at the lowest possible cost. Two-hundred-five hospital workers from the Piedmont region of Italy participated in the study. The sero-epidemiological conditions of this group with regard to hepatitis B markers was representative of hospital workers in this region as a whole. All subjects, excluding carriers, persons with anti-HBs titers greater than or equal to 10 mIU and subjects positive for anti-HBc at a 1/100 dilution, were vaccinated. Their responses were evaluated 15 days and 1 month after vaccination. The presence of a booster effect following vaccination was correlated with the immunological status of the subject at the time of pre-vaccination screening. In the light of the results obtained, 5 screening procedures and the procedure of vaccination without screening were evaluated. The most cost effective screening strategy proved to be that of sequential testing for anti-HBc, anti-HBs and finally HBsAg and vaccination of the following subjects: those who were negative for anti-HBc, those who were anti-HBc-positive with anti-HBs titers 10 less than mIU and those who were HBsAg negative.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108025     DOI: 10.1007/bf00145068

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  4 in total

1.  Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection.

Authors:  R J Sherertz; E Spindel; J H Hoofnagle
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

2.  Response to hepatitis B virus vaccine in subjects with low levels of antibody to hepatitis B surface antigen.

Authors:  R P Perrillo; C Bodicky; C Campbell; G E Sanders
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

3.  The British National Health Service.

Authors: 
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

4.  Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

Authors:  A G Mulley; M D Silverstein; J L Dienstag
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

  4 in total
  1 in total

Review 1.  Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.

Authors:  S M Holliday; D Faulds
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.